Study Completed

Multiple Sclerosis

Bayer Identifier:

308100

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

"BRIGHT" (Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal

454

Trial Dates

June 2004 - February 2006

Phase

N/A

Could I Receive a placebo

N/A

Products

Betaseron (Interferon beta-1b, BAY86-5046)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location

Primary Outcome

Secondary Outcome

Trial design

"BRIGHT"(Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients treated with Betaferon® vs. Rebif®

Trial Type

Observational

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.